Longeveron Inc. Insider Trading

LGVN

⊜ Compare

Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Aug 2025.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

Aug 2025

Aug 11, 2025

Get an email when LGVN's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 11, 2025	Lisa Locklear Chief Financial Officer	Bought	11,766	—	—	4.9%	Form 4
Aug 11, 2025	Khoso Baluch Director	Bought	11,766	—	—	29%	Form 4
May 29, 2025 – May 30, 2025	Rock Soffer Director	SoldNo plan 2 parts	21,000	$1.27 average	27K	9.1%	Form 4
May 22, 2025	Rock Soffer Director	SoldNo plan	2,000	$1.32	3K	0.9%	Form 4
May 16, 2025	Joshua Hare Chief Scientific Officer	SoldNo plan	5,250	$1.40	7K	0.7%	Form 4
Dec 2, 2024	Khoso Baluch Director	SoldNo plan	1,250	$2.07	3K	5.0%	Form 4

Aug 11, 2025
Lisa Locklear
Chief Financial Officer · bought 11,766
—
4.9% of stake
Aug 11, 2025
Khoso Baluch
Director · bought 11,766
—
29% of stake
May 29, 2025 – May 30, 2025No plan
Rock Soffer
Director · sold 21,000 at avg $1.27
27K
9.1% of stake
May 22, 2025No plan
Rock Soffer
Director · sold 2,000 at $1.32
3K
0.9% of stake
May 16, 2025No plan
Joshua Hare
Chief Scientific Officer · sold 5,250 at $1.40
7K
0.7% of stake
Dec 2, 2024No plan
Khoso Baluch
Director · sold 1,250 at $2.07
3K
5.0% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch LGVN, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with LGVN

CompareIntrinsic value

ALXOAlx Oncology Holdings Inc.

$1.36+5.43%10

NEUPNeuphoria Therapeutics Inc.

$2.98-0.33%10

SXTP60 Degrees Pharmaceuticals Inc.

$0.96-5.32%40

IGCIGC Pharma Inc.

$0.20+5.26%26

ORGSOrgenesis Inc.

$0.05+0.00%20

DAREDare Bioscience Inc.

$0.66+1.83%10

STTKShattuck Labs Inc.

$5.29-3.38%40

TERNTerns Pharmaceuticals, Inc.

$0.01-8.89%10

Spot a number that looks wrong? Check it in LGVN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing LGVN

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.